Literature DB >> 17339311

Mesalazine-induced bronchiectasis and eosinophilia in a patient with ulcerative colitis: a case report.

L C Price1, A Poullis, S Grubnic, J Y Kang, C F J Rayner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17339311      PMCID： PMC1809164          DOI： 10.1177/014107680710000314

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  8 in total

1.  Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.

Authors:  G Haralambou; A S Teirstein; J Gil; D H Present
Journal:  Mt Sinai J Med       Date:  2001-11

2.  Adverse pulmonary effects of mesalamine.

Authors:  A Muzzi; F Ciani; D Bianchini; G Festini; C Volpe
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

3.  Clinical and radiological characteristics of lung disease in inflammatory bowel disease.

Authors:  R Mahadeva; G Walsh; C D Flower; J M Shneerson
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

4.  Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.

Authors:  Runi A Foster; Dani S Zander; Patricia J Mergo; John F Valentine
Journal:  Inflamm Bowel Dis       Date:  2003-09       Impact factor: 5.325

5.  Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.

Authors:  S N Sullivan
Journal:  J Clin Gastroenterol       Date:  1987-08       Impact factor: 3.062

6.  Sulfasalazine-induced pulmonary disease.

Authors:  M A Hamadeh; J Atkinson; L J Smith
Journal:  Chest       Date:  1992-04       Impact factor: 9.410

Review 7.  Mesalamine-induced lung toxicity.

Authors:  A Bitton; M A Peppercorn; J P Hanrahan; M P Upton
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

Review 8.  The lung in inflammatory bowel disease.

Authors:  P Camus; F Piard; T Ashcroft; A A Gal; T V Colby
Journal:  Medicine (Baltimore)       Date:  1993-05       Impact factor: 1.889
  8 in total
  3 in total

1.  Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Authors:  José Ferrusquía; Isabel Pérez-Martínez; Ricardo Gómez de la Torre; María Luisa Fernández-Almira; Ruth de Francisco; Luis Rodrigo; Sabino Riestra
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 2.  Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations.

Authors:  Cristina Bezzio; Cristina Della Corte; Marta Vernero; Imma Di Luna; Gianpiero Manes; Simone Saibeni
Journal:  Therap Adv Gastroenterol       Date:  2022-07-28       Impact factor: 4.802

3.  Ulcerative colitis-associated bronchiectasis: A rare extraintestinal manifestation of inflammatory bowel disease: A case report.

Authors:  Marouf Alhalabi; Sawsan Ali Deeb; Fadwa Ali; Ahmad Abbas
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.